BFM
EW icon

Boothbay Fund Management’s Edwards Lifesciences EW Stock Holding History

Boothbay Fund Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$574K Buy
7,172
+3,971
+124% +$327K 0.01% 1267
2025
Q4 		$273K Sell
3,201
-228
-7% -$18.7K ﹤0.01% 1492
2025
Q3 		$267K Buy
+3,429
New +$268K ﹤0.01% 1510
2024
Q4 		– Sell
-9,770
Closed -$645K – 1618
2024
Q3 		$645K Buy
+9,770
New +$710K 0.01% 903
2024
Q2 		– Sell
-11,974
Closed -$1.14M – 1627
2024
Q1 		$1.14M Buy
+11,974
New +$1.01M 0.02% 715
2023
Q4 		– Sell
-6,028
Closed -$418K – 1747
2023
Q3 		$418K Buy
+6,028
New +$484K 0.01% 1117
2023
Q2 		– Sell
-5,279
Closed -$437K – 1951
2023
Q1 		$437K Buy
5,279
+920
+21% +$72.3K 0.01% 1308
2022
Q4 		$325K Sell
4,359
-1,512
-26% -$117K 0.01% 1349
2022
Q3 		$485K Buy
5,871
+3,693
+170% +$355K 0.01% 1254
2022
Q2 		$207K Sell
2,178
-1,145
-34% -$119K 0.01% 1723
2022
Q1 		$391K Buy
+3,323
New +$373K 0.01% 1443
2021
Q2 		– Sell
-6,178
Closed -$517K – 1923
2021
Q1 		$517K Buy
+6,178
New +$522K 0.02% 930
2020
Q1 		– Sell
-3,756
Closed -$292K – 910
2019
Q4 		$292K Buy
+3,756
New +$293K 0.03% 603
2019
Q3 		– Sell
-3,717
Closed -$229K – 807
2019
Q2 		$229K Buy
+3,717
New +$225K 0.02% 583
2018
Q1 		– Sell
-5,418
Closed -$204K – 738
2017
Q4 		$204K Buy
+5,418
New +$199K 0.03% 587
2017
Q1 		– Sell
-16,659
Closed -$520 – 802
2016
Q4 		$520 Buy
+16,659
New +$540K 0.12% 224

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Boothbay Fund Management's EW Position: Q1 2026 in Review

Boothbay Fund Management increased its Edwards Lifesciences (EW) stake by 124% in Q1 2026, buying an estimated $327K and bringing the position to 7,172 shares worth $574K. The position accounts for 0.01% of the portfolio, ranked #1267.

Boothbay Fund Management first reported a position in EW in Q4 2016 and has held it in 16 quarters since. The position peaked at $1.14M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Boothbay Fund Management held 7,172 shares of Edwards Lifesciences worth $574K as of Q1 2026.
  • Boothbay Fund Management bought 3,971 Edwards Lifesciences shares in Q1 2026, an estimated $327K.
  • Edwards Lifesciences made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1267 holding.
  • Boothbay Fund Management first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 16 quarters since.
  • Boothbay Fund Management's Edwards Lifesciences position peaked at $1.14M in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.